D-Index & Metrics Best Publications

Meenhard Herlyn

The Wistar Institute
United States

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 133 Citations 66,788 648 World Ranking 1242 National Ranking 733

Biology and Biochemistry D-index 134 Citations 67,703 660 World Ranking 239 National Ranking 171

Overview

What is he best known for?

The fields of study Meenhard Herlyn is best known for:

Gene
Apoptosis
Cancer

Cancer research is frequently linked to Nevus in his study. In his research, Meenhard Herlyn performs multidisciplinary study on Nevus and Dysplastic nevus. His research brings together the fields of Cancer research and Dysplastic nevus. Meenhard Herlyn carries out multidisciplinary research, doing studies in Melanoma and Metastasis. He performs integrative study on Metastasis and Melanoma in his works. In most of his Immunology studies, his work intersects topics such as Effector. He frequently studies issues relating to Immunology and Effector. His Biochemistry study frequently draws parallels with other fields, such as Cell growth. Meenhard Herlyn integrates several fields in his works, including Cell growth and Gene.

His most cited work include:

Characterization of nerve growth factor receptor in neural crest tumors using monoclonal antibodies. (273 citations)
Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. (261 citations)
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations (188 citations)

What are the main themes of his work throughout his whole career to date

His Cell biology study frequently links to other fields, such as Signal transduction and Kinase. In most of his Signal transduction studies, his work intersects topics such as Cell biology. His study deals with a combination of Cancer research and Melanoma. Meenhard Herlyn performs multidisciplinary study in Melanoma and Melanocyte in his work. His Melanocyte study frequently involves adjacent topics like Cancer research. As part of his studies on Genetics, he often connects relevant subjects like Cell culture. Cell culture is frequently linked to Genetics in his study. Immunology is closely attributed to Immunohistochemistry in his work. His work on Immunology expands to the thematically related Immunohistochemistry.

Meenhard Herlyn most often published in these fields:

Cancer research (64.29%)
Melanoma (54.76%)
Genetics (47.62%)

What were the highlights of his more recent work (between 2010-2021)?

Gene (66.67%)
Cancer (66.67%)
Genetics (66.67%)

In recent works Meenhard Herlyn was focusing on the following fields of study:

His research is interdisciplinary, bridging the disciplines of Copy number analysis and Gene. He performs multidisciplinary study in the fields of Copy number analysis and Copy-number variation via his papers. Copy-number variation and Genome are two areas of study in which Meenhard Herlyn engages in interdisciplinary work. Meenhard Herlyn connects Genome with Microarray in his study. His research combines Genetics and Microarray. His Genetics study frequently links to adjacent areas such as Fight-or-flight response. The study of Fight-or-flight response is intertwined with the study of Gene in a number of ways. His multidisciplinary approach integrates Cancer and Colorectal cancer in his work. Meenhard Herlyn incorporates Colorectal cancer and Cancer in his studies.

Between 2010 and 2021, his most popular works were:

Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts (92 citations)
A slow-cycling subpopulation of melanoma cells with highly invasive properties (57 citations)
Erratum: A stress-induced early innate response causes multidrug tolerance in melanoma (40 citations)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

Vassilis G. Gorgoulis;Leandros-Vassilios F. Vassiliou;Panagiotis Karakaidos;Panayotis Zacharatos.
Nature (2005)

2304 Citations

Colorectal carcinoma antigens detected by hybridoma antibodies

Hilary Koprowski;Zenon Steplewski;Kenneth Mitchell;Meenhard Herlyn.
Somatic Cell and Molecular Genetics (1979)

1931 Citations

A tumorigenic subpopulation with stem cell properties in melanomas.

Dong Fang;Thiennga K. Nguyen;Kim Leishear;Rena Finko.
Cancer Research (2005)

1593 Citations

A promoter-level mammalian expression atlas

Alistair R.R. Forrest;Hideya Kawaji;Michael Rehli;J. Kenneth Baillie.
Nature (2014)

1550 Citations

Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

James Tsai;John T. Lee;Weiru Wang;Jiazhong Zhang.
Proceedings of the National Academy of Sciences of the United States of America (2008)

1454 Citations

Exosomal PD-L1 Contributes to Immunosuppression and is Associated with anti-PD-1 Response

Gang Chen;Alexander C. Huang;Wei Zhang;Wei Zhang;Gao Zhang.
Nature (2018)

1386 Citations

Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3K

Jessie Villanueva;Adina Vultur;John T. Lee;Rajasekharan Somasundaram.
Cancer Cell (2010)

1380 Citations

BRAF and RAS mutations in human lung cancer and melanoma

Marcia S. Brose;Patricia Volpe;Michael Feldman;Madhu Kumar.
Cancer Research (2002)

1373 Citations

A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth

Alexander Roesch;Mizuho Fukunaga-Kalabis;Elizabeth C. Schmidt;Susan E. Zabierowski.
Cell (2010)

1188 Citations

Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression

Steven M. Albelda;Stephen A. Mette;David E. Elder;RoseMary Stewart.
Cancer Research (1990)

1155 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Meenhard Herlyn